Azapropazone
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Overview
Azapropazone is a non-steroidal anti-inflammatory drug. It is manufactured by Goldshield under the tradename Rheumox.[1]
It was available in the UK as a prescription-only drug, with restrictions due to certain contra-indications and side-effects.[2] Azopropazone has now been discontinued in the British National Formulary.
Azapropazone has a half-life of approximately 20 hours in humans and is not extensively metabolized.[3]
References
References
- ↑ http://home.intekom.com/pharm/cont_eth/rheumox.html
- ↑ http://www.patient.co.uk/showdoc/30002267/
- ↑ Jones CJ (1976). “The pharmacology and pharmacokinetics of azapropazone – a review”. Curr Med Res Opin. 4 (1): 3–16. doi:10.1185/03007997609109361. PMID 770078.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH